Related by context. All words. (Click for frequent words.) 68 germline mutations 66 familial clustering 65 Genetic variants 65 chorioamnionitis 65 fetal malformations 65 inherited mutations 65 spontaneous mutations 65 microdeletion 65 microdeletions 65 monogenic 65 susceptibility genes 65 HLA DRB1 65 GBA mutations 65 NNRTI resistance 65 mutated K ras 64 missense mutations 64 epigenetic changes 64 monozygotic twins 64 p# mutation 64 brain lesions 64 Genetic predisposition 64 genetic variants associated 64 genetic loci 64 chromosomal aberrations 64 coinfection 64 K ras mutations 64 nonhereditary 63 FGFR2 gene 63 Chronic pancreatitis 63 de novo mutations 63 PTEN mutations 63 spontaneous mutation 63 JAK mutations 63 GSTM1 63 sporadic ALS 63 precursor lesions 63 biochemical abnormalities 63 mitochondrial mutations 63 HER2 expression 63 histologic subtype 63 susceptibility gene 63 genetic polymorphisms 63 obstructive coronary artery 63 p# mutations 63 IgA deficiency 63 penetrance 62 utero exposure 62 IKZF1 62 chlamydial infection 62 atypical hyperplasia 62 mesotheliomas 62 chromosomal abnormalities 62 herpesviruses 62 transfusion syndrome 62 chromosomal deletions 62 dizygotic twins 62 genes predisposing 62 genetic abnormalities 62 etiologic 62 carotid plaques 62 aneuploidies 62 congenital anomalies 62 alleles 62 deleterious mutations 62 chromosomal disorders 62 PTPN# 62 TCF#L# gene 62 colorectal neoplasia 62 TT genotype 62 recurrent miscarriage 62 testicular tumors 62 MGUS 62 infarcts 62 basal cell nevus syndrome 62 developmental abnormalities 62 causal variants 62 S. maltophilia 62 familial ALS 62 seropositivity 61 carbohydrate intolerance 61 LRRK2 mutations 61 pathogenic mutations 61 LRRK2 gene 61 underlying pathophysiology 61 causative mutation 61 methylation patterns 61 hamartoma 61 monozygotic twin 61 sCJD 61 K ras gene 61 HNSCC 61 EBV infection 61 colorectal polyp 61 chromosome #q# [002] 61 chromosomal anomalies 61 APOE e4 61 Li Fraumeni syndrome 61 hypermethylated 61 chromosomal mutations 61 APOE ε4 61 chromosomal regions 61 inherited predisposition 61 neoplasias 61 monoclonal gammopathy 61 hereditary predisposition 61 thyroid hormone levels 61 chromosome #q# [001] 61 Genetic mutation 61 APOE genotype 61 elevated CRP 61 serum BDNF 61 chromosomal rearrangement 61 Immune responses 61 untreated celiac disease 61 genetic aberrations 61 #q#.# deletion syndrome 61 familial aggregation 61 neuroligins 61 hamartomas 61 predisposing factor 61 ADAMTS# 61 ABCB1 61 phenotypic variation 60 allele frequencies 60 Genetic variation 60 mosaicism 60 TP# mutations 60 SLC#A# [002] 60 pre malignant lesions 60 #p#.# [001] 60 ADPKD 60 neurodevelopmental impairment 60 thrombophilia 60 chromosome #q#.# [001] 60 MTHFR 60 p# activation 60 G6PD deficiency 60 genetic abnormality 60 metabolic abnormality 60 MSH2 60 hippocampal volumes 60 adenomatous polyp 60 colonic mucosa 60 genetic susceptibilities 60 neurodevelopmental outcome 60 cranial irradiation 60 DNA methylation patterns 60 mtDNA mutations 60 placental malaria 60 Genetic variations 60 apolipoprotein E gene 60 HbF 60 molecular abnormalities 60 astrocytomas 60 OGG1 60 SE alleles 60 heterozygotes 60 susceptibility loci 60 recessive inheritance 60 cryptogenic 60 intestinal polyps 60 chromosomal anomaly 60 hepatocellular carcinomas 60 heritable variation 60 splice junctions 60 prenatally diagnosed 60 nerve degeneration 60 endogenous estrogen 60 genetic syndromes 60 somatic mutations 60 FGFs 60 proximal colon 60 isotypes 60 MLH1 60 enterocolitis 60 multi factorial disease 60 chromosomal instability 60 MYCN amplification 60 genomic deletions 60 nongenetic 60 neurodevelopmental outcomes 60 recurrent miscarriages 60 FGFR2 60 TP# mutation 60 airway hyperresponsiveness 60 TGFBR1 * 6A 60 thyroid carcinoma 60 varicella infection 60 gene rearrangements 59 Heavy menstrual bleeding 59 glycated hemoglobin levels 59 heterozygosity 59 distal colon 59 rs# [004] 59 skeletal metastases 59 KRAS mutations 59 IDH mutations 59 autosomal 59 chromosomal imbalance 59 CMV infections 59 metabolic abnormalities 59 dopamine transporter gene 59 hormone receptor negative 59 neurocognitive deficits 59 prostate cancer CaP 59 Bacterial vaginosis 59 gastric carcinoma 59 mutations 59 TMPRSS2 ERG fusion 59 congenital abnormalities 59 CHD7 59 apolipoprotein E4 59 UGT#B# 59 epithelial tumors 59 klotho 59 ovulatory cycles 59 MECP2 gene 59 nonmelanoma skin cancers 59 holoprosencephaly 59 GSTT1 59 conditional logistic regression 59 thyrotropin levels 59 preterm deliveries 59 #q#.# [001] 59 chromosome rearrangements 59 #q# deletion 59 breast cancer subtypes 59 polycystic ovary syndrome PCOS 59 HIV HCV coinfected 59 biochemical marker 59 seminomas 59 chromosome #p#.# 59 somatic mutation 59 GBM tumors 59 HPV subtypes 59 nucleotide substitutions 59 prenatal exposures 59 karyotype 59 precancerous polyp 59 orchitis 59 Genetic mutations 59 gene polymorphisms 59 neural tube defect 59 hippocampal atrophy 59 serum biomarkers 59 #p#.# [002] 59 abnormalities 59 airway responsiveness 59 antenatal depression 59 synovial cells 59 C. pneumoniae 59 prothrombotic 59 haemochromatosis 59 de ath 59 bronchopulmonary dysplasia 59 modifier genes 59 C. neoformans 59 homozygosity 59 congenital malformations 59 shortened telomeres 59 CC genotype 59 hyperinsulinism 59 genomic alterations 59 lobular breast cancer 59 aneuploid cells 59 advanced adenomas 59 aortic atherosclerosis 59 precancerous condition 59 CSF biomarkers 59 glial tumors 59 chronicity 59 SMAD4 59 recurrent VTE 59 albumin excretion 59 serous ovarian cancer 59 subclinical 59 IUGR 59 proband 59 genetic mutations 59 Telomere length 59 TRAF1 C5 59 gene amplification 59 hypoperfusion 59 neurodevelopmental disorder 59 etiologic factors 59 teratogens 59 activated microglia 59 gene variants 59 congenital disorders 59 enteroviral 59 postnatally 59 allelic variants 59 tumor histology 59 CDH1 59 SSc 59 esophageal squamous cell carcinoma 59 Multivariate analysis 59 cervical lymph nodes 59 HNPCC 59 microsatellite instability 59 gestational diabetes mellitus GDM 59 promoter hypermethylation 59 phenotypic expression 58 male hormone androgen 58 neurological sequelae 58 PARP inhibition 58 adnexal mass 58 BMPR2 58 serum cotinine levels 58 Logistic regression analysis 58 gene APOE 58 microbleeds 58 familial pancreatic cancer 58 serum concentrations 58 #q#.# [002] 58 ependymomas 58 T. vaginalis 58 enterovirus infection 58 germline mutation 58 troponin T 58 hippocampal volume 58 LRAT 58 neurologic complications 58 invasive carcinoma 58 epigenetic alterations 58 MYH9 58 APOL1 58 arterial calcification 58 bronchopulmonary dysplasia BPD 58 lymph node metastasis 58 PALB2 58 microRNA expression 58 telomere lengths 58 subclinical hyperthyroidism 58 psychiatric comorbidity 58 testicular germ cell 58 LV dysfunction 58 thyroid deficiency 58 generalized epilepsy 58 invasive lobular 58 Cognitive impairment 58 parasitaemia 58 karyotypes 58 neurocognitive impairment 58 differential gene expression 58 PON1 58 nonmelanoma 58 molar pregnancy 58 CFH gene 58 ovarian hormones 58 familial adenomatous polyposis FAP 58 phenotype 58 atopy 58 genetically inherited 58 spontaneous miscarriages 58 CYP#B# 58 Subgroup analyzes 58 subclinical atherosclerosis 58 causative gene 58 epithelial tissues 58 endostatin 58 BRCA1 mutations 58 mitochondrial dysfunction 58 leiomyoma 58 cardioembolic stroke 58 familial adenomatous polyposis 58 renal cell carcinomas 58 diagnostic biomarker 58 serum PTH 58 renal scarring 58 PCNSL 58 pancreatic endocrine 58 phenotypic characteristics 58 endometrial hyperplasia 58 perinatal complications 58 endophenotypes 58 coagulopathy 58 pilocytic astrocytomas 58 preeclamptic 58 gonococcal infection 58 mammary tumors 58 chromosomal defects 58 nodal metastasis 58 ORMDL3 58 GISTs 58 CNTNAP2 58 gene expression patterns 58 gene loci 58 APOE gene 58 mRNA expression 58 chlamydial 58 incidentalomas 58 premalignant lesions 58 axonal degeneration 58 carotid plaque 58 lung adenocarcinomas 58 eosinophil count 58 atypical nevi 58 abnormal chromosomes 58 molecular subtypes 58 neuroblastoma tumors 58 miRNA expression 58 multivariable analysis 58 genetic determinants 58 systemic amyloidosis 58 chromosome abnormality 58 Klinefelter syndrome 58 subclinical hypothyroidism 58 hippocampal function 58 eotaxin 58 recurrent venous thromboembolism 58 HLA B# 58 cytogenetic abnormalities 58 nonischemic 58 C1q 58 APOC3 58 metabolic disturbances 58 ABCB1 gene 58 intact parathyroid hormone 58 chromosome translocations 58 autosomal dominant inheritance 58 microscopic colitis 58 BRCA gene mutation 58 Colon polyps 58 coronary stenoses 58 clinically insignificant 58 comorbid disorders 58 rs# [001] 58 genetic alterations 58 alpha thalassemia 58 CAG repeats 58 DNA rearrangements 58 phthalate syndrome 58 Brugada syndrome 58 BRCA mutation 58 MYH9 gene 58 KRAS oncogene 58 neoplasm 58 cytopathic 58 DRB1 * 58 G#S mutation 58 SNP rs# [001] 58 autism susceptibility genes 58 chromosome #p# [002] 58 CIN3 58 myocardial fibrosis 58 gene deletions 57 heritability 57 chromosome aberrations 57 homozygotes 57 presymptomatic 57 microcephalin 57 ischemic lesions 57 mucinous 57 Hashimoto thyroiditis 57 TYMS 57 CYP#D# genotype 57 Univariate analysis 57 node metastases 57 normal karyotype 57 pathological hallmark 57 colorectal adenoma 57 grade serous ovarian 57 allelic 57 Endothelial dysfunction 57 MHC genes 57 histological subtype 57 subclinical disease 57 chromosomal defect 57 motor neuron degeneration 57 neuronal dysfunction 57 biologic pathways 57 ZNF# 57 leiomyomas 57 2D 4D ratio 57 CCR5 delta# 57 hyperplastic 57 MAPK pathway 57 liver metastasis 57 neurologic symptoms 57 Chlamydia infection 57 CYP#D# gene 57 mutant huntingtin protein 57 K ras mutation 57 epigenetic markers 57 myopathies 57 deletion 5q 57 NKX2 57 da mage 57 antiphospholipid antibodies 57 causative genes 57 pre eclamptic 57 gastric adenocarcinoma 57 metastatic lymph nodes 57 sequence homology 57 poorer prognosis 57 highly heritable 57 Leydig cell 57 EGFR mutations 57 unmeasured confounding 57 lung epithelium 57 apolipoprotein E APOE 57 GATA4 57 medulloblastomas 57 neurologic deficits 57 endometrial carcinoma 57 Folate deficiency 57 retinal dysfunction 57 APOE4 57 advanced adenoma 57 MEF2A 57 rCBF 57 breast endometrial 57 spontaneous preterm birth 57 PTEN gene 57 acute lymphoid leukemia 57 Li Fraumeni 57 HER2 overexpression 57 gestational diabetes mellitus 57 idiopathic pulmonary arterial hypertension 57 renal carcinoma 57 cellularity 57 impair fertility 57 aneuploidy 57 UVB induced 57 elevated triglyceride levels 57 STAT4 57 cortical thinning 57 genomic imprinting 57 vestibular schwannomas 57 UGT#A# * 57 HGPS 57 heterozygote 57 Immunohistochemical analysis 57 immunohistochemical staining 57 thrombotic complications 57 CNVs 57 Brain metastases 57 carotid atherosclerosis 57 androgen deprivation 57 BRCA mutation carriers 57 homozygote 57 obstructive coronary 57 gynecologic malignancy 57 LVNC 57 Spinal muscular atrophy 57 GSTM1 gene 57 haplotypes 57 clefting 57 complete cytogenetic response 57 Pneumocystis carinii pneumonia 57 micronuclei 57 genetic polymorphism 57 SLNB 57 EoE 57 PSADT 57 GPC5 57 sexual dimorphism 57 cerebral microbleeds 57 Hutchinson Gilford progeria 57 endometrial thickness 57 LRP5 57 plasma kallikrein 57 FDG PET scans 57 Oxidative damage 57 neovascular 57 serotonin synthesis 57 LPA gene 57 gene mutations 57 atherosclerotic lesion 57 schizophreniform disorder 57 amyloid plaque formation 57 extramedullary 57 chromosome #p# [001] 57 genetic susceptibility 57 #p# [001] 57 BRAF V#E 57 precancerous cervical 57 allergic eczema 57 BRCA2 gene mutation 57 narcolepsy cataplexy 57 subsyndromal 57 survivin expression 57 atypia 57 splice variants 57 pathophysiologic 57 necrotic core 57 MCADD 57 pleiotropic effects 57 acute rheumatic fever 57 CMV infection 57 genetic locus 57 aneuploid 57 bowel polyps 57 malformations 57 Gorlin syndrome 57 apoE4 57 remnant lipoproteins 57 hepatocellular carcinoma liver 57 dominantly inherited 57 advanced neoplasia 57 clinically detectable 57 cervical secretions 57 latent celiac disease 57 ultra rapid metabolizer 57 breast carcinomas 57 perinatal asphyxia 57 rs# [002] 57 QTLs 57 coronary calcification 57 KCNH2 57 Bonferroni correction 57 Fas ligand 57 nephrogenic 57 CagA 57 chromosome abnormalities 57 BCL#A 57 leukoencephalopathy 57 mammary cancers 57 TNF blocker therapy 57 repolarization 57 pyloric stenosis 57 lymphatic cancers 57 antibody titer 57 HER2 positive cancers 57 perioperative complications 57 metabolite concentrations 57 polycystic kidneys 57 chromosomal rearrangements 57 hematopoietic cancers 57 contralateral breast cancer 57 cytogenic 57 mutant allele 57 lung adenocarcinoma 57 diagnosed prenatally 57 apoE 57 cyclin E 57 enteroviral infection 57 recessive genetic 57 SUVmax 57 CD# expression [001] 57 corticosterone levels 57 adrenal function 57 lymph node metastases 57 acetabular dysplasia 57 dysglycemia 57 Malignant tumors 57 HMGA2 57 Hurthle cell 57 locoregional recurrence 57 chromosomal translocations 57 mammographic density 57 invasive ductal breast cancer 57 ERBB2 57 filaggrin mutations 57 chromosomal abnormality 57 colorectal polyps 57 morphological abnormalities 57 polyhydramnios 57 monozygotic 56 gene MECP2 56 oncogenic mutations 56 gene polymorphism 56 CLA supplementation 56 hormone receptor status 56 environmental toxicants 56 MC1R 56 methylation markers 56 microglial 56 menstrual abnormalities 56 neonatal morbidity 56 ependymoma 56 NNRTI resistant virus 56 stratifying patients 56 AAT deficiency 56 dopamine receptor gene 56 pulmonary toxicity 56 malarial anemia 56 hyperacute 56 cystatin C 56 HLA genes 56 neurological abnormalities 56 squamous cell lung cancer 56 phenotypic differences 56 SIDS infants 56 gastric cardia 56 serologically 56 KIAA# 56 globin genes 56 pathogenic mechanisms 56 MTHFD1L gene 56 abnormal lipid 56 malignant neoplasm 56 neuropsychiatric diseases 56 nondemented 56 type2 diabetes 56 anatomical abnormalities 56 Fragile X gene 56 Malignant mesothelioma 56 CHEK2 56 E selectin 56 neurofibroma 56 thyroid nodule 56 huntingtin gene 56 persistent pulmonary hypertension 56 gastrointestinal dysfunction 56 polypoid lesions 56 CP CPPS 56 suppressor gene 56 polyp recurrence 56 organophosphate exposure 56 LIS1 56 KRAS status 56 hereditary nonpolyposis colorectal cancer 56 tryptase 56 SHANK3 56 DHEA supplementation 56 habitual snoring 56 orofacial clefts 56 amyloid peptide 56 GSTP1 56 supratentorial 56 prognostic indicator 56 tertile 56 exotropia 56 Male infertility 56 CVD mortality 56 excitatory synapses 56 Previous epidemiological studies 56 genetic variation 56 B7 H3 56 genomewide 56 MC4R gene 56 parous women 56 prostate cancer PCa 56 lung metastasis 56 coronary stenosis 56 etiologic agent 56 obstructive CAD 56 mitochondrial disorders 56 fetal aneuploidy 56 ascertainment bias 56 Rh factor 56 PrPSc 56 p# biomarker 56 mitochondrial DNA mutations 56 artery stenosis 56 fluoroquinolone resistance 56 TACI mutations 56 NF1 56 polymorphisms 56 leptin deficiency 56 GABRA2 56 urolithiasis 56 LRRK2 mutation 56 nuchal translucency 56 Subgroup analysis 56 causative mutations 56 genomewide association studies 56 Clusterin 56 predisposing factors 56 FASPS 56 virulence genes 56 nodal metastases 56 fronto temporal dementia 56 periventricular 56 clostridia 56 superinfection 56 gonococcal 56 carotid stenosis 56 human leukocyte antigens 56 lymphocytic 56 ERK signaling 56 BDNF gene 56 granulosa cell 56 precancerous tumors 56 renal cysts 56 HGPIN 56 autosomal recessive disease 56 amyloid deposition 56 histone deacetylases 56 epigenetic modifications 56 colocalization 56 breast cancer susceptibility genes 56 genetic variant 56 hepatic liver 56 BRAF mutation 56 carcinoid tumor 56 deCODE BreastCancer TM 56 histocompatibility 56 gonadal hormones 56 HER2 amplification 56 angiographically 56 MMP# 56 antiphospholipid syndrome 56 neovascularisation 56 aneuploidy screening 56 Histopathologic examination 56 hyper IgE syndrome 56 idiopathic pulmonary 56 prognostic marker 56 embryonal 56 autistic traits 56 schizotypal traits 56 TMEM density 56 histopathologic examination 56 nonalcoholic steatohepatitis NASH 56 epigenetic silencing 56 Multivariate analyzes 56 rs# [003] 56 underlying molecular mechanisms 56 ductal lobular 56 multivariable adjusted 56 loci 56 Calcium intake 56 multivariate logistic regression 56 neurologic sequelae 56 Logistic regression 56 confounder 56 poor metabolizers 56 heterozygous 56 hyperplastic polyps 56 mutation 56 congenital CMV 56 intracellular bacteria 56 FMR1 gene 56 TP# gene 56 ApoE gene 56 allele frequency 56 circadian clock genes 56 Vitamin D insufficiency 56 gametocytes 56 hydrops 56 toxoplasma 56 hypercalciuria 56 glutamate signaling 56 subcellular compartments 56 acute leukemias 56 metabolic dysfunction 56 dyskeratosis congenita 56 Lafora disease 56 ductal breast cancer 56 adenocarcinomas 56 FMR1 56 renal fibrosis 56 gene APOE4 56 mRNA transcripts 56 genetic defects 56 neuroblastomas 56 bile acid metabolism 56 hereditary hemochromatosis 56 intraventricular hemorrhage 56 plasma triglycerides 56 prostate carcinogenesis 56 prostate carcinoma 56 BARD1 56 neonatal lupus 56 behavioral disinhibition 56 protein tyrosine phosphatase 56 ovarian endometrial 56 FTLD 56 SRBD 56 contralateral breast 56 coronary blockages 56 normal prion proteins 56 Vitamin B# deficiency 56 mutant genes 56 prion infection 56 atherosclerotic lesions 56 T1DM 56 allogeneic HSCT 56 HLA molecules 56 microRNA molecules 56 malignant nodules 56 G allele 56 lactate dehydrogenase 56 hyperalgesia 56 LQTS 56 susceptibility alleles 56 papillary renal cell carcinoma 56 Microarray analysis 56 Treg cell 56 ectopic 56 dizygotic 56 nonvaccine 56 FeNO 56 sonographic diagnosis 56 immunodeficiencies 56 sFlt1 56 adenomatous polyps 56 epigenetically 56 depressive symptomatology 56 atopic 56 DSM IV diagnosis 56 psychosocial variables 56 aetiological 56 clinicopathological 56 pituitary hormone 56 neurofibromas 56 untreated hypothyroidism 56 RRM1 56 recessive trait 56 myometrium 56 insulin resistance syndrome 56 colorectal carcinoma 56 HER2 neu 56 immunopathology 56 hypermethylation 56 genetic variants 56 p# Shc 56 unexplained mental retardation 56 neurosensory 56 GIST tumors 56 uterine tumors 56 PITX2 56 COMT gene 56 endometrial cancers 56 circulating endothelial cells 56 metastatic tumors 56 deafness meningitis 56 malignant prostate 56 mitochondrial defects 56 Candida species 56 abnormal chromosome 56 lymphangiogenesis 56 IGFBP 3 56 puerperal psychosis 56 N. gonorrhoeae 56 aortic stiffness 56 BRAF gene 56 ApoE4 56 unmeasured factors 56 radiographic findings 56 alkalosis 56 mutated genes 56 HMGCR 56 SPINK1 56 ApoE4 gene 56 CDKN2A 56 myocardial ischaemia 56 TCF#L# 56 medium chain acyl 56 oesophageal adenocarcinoma 56 neuropsychological impairment 56 interobserver reliability 56 herpes simplex encephalitis 56 malignant polyps 56 autosomal recessive 56 SRY gene 56 MLL2 56 chronic hepatitis cirrhosis 56 Kufs disease 56 FDG uptake 56 filaggrin 56 fetal chromosomal 55 distinct subtypes 55 CTEPH 55 overt hypothyroidism 55 uterine scar 55 thyroid abnormalities 55 paraganglioma 55 Epstein Barr virus EBV 55 functional polymorphism 55 cysteines 55 HLA DQ2 55 microvessels 55 enterotypes 55 GBMs 55 MSMB 55 ovarian malignancy 55 euthymic patients 55 immunoreactivity 55 mental retardation epilepsy 55 M. pneumoniae 55 bronchial epithelial cells 55 thyrotropin 55 Rh incompatibility 55 cerebellar vermis 55 undiagnosed celiac disease 55 myeloproliferative 55 pre cancerous lesion 55 cystic fibrosis muscular dystrophy 55 congenital deficiency 55 PALB2 gene 55 metabolizer 55 endoxifen 55 chemosensitivity 55 Legg Calvé Perthes disease 55 susceptibility locus 55 teratoma 55 TMEM#B 55 metaplasia 55 Abdominal aortic aneurysms 55 S. sanguinis 55 white matter hyperintensities 55 colonic polyps 55 microscopic hematuria 55 fetal anomalies 55 dysmorphic features